ZK 230211

· Bayer

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ZK 230211, covering 2014-10-10 to 2014-10-10. Get the full timeline:

Most recent: Clinical Trial Update: ZK 230211 in Postmenopausal Woman With Metastatic Breast Cancer [Phase 2]